stoxline Quote Chart Rank Option Currency Glossary
PROCEPT BioRobotics Corporation (PRCT)
50.19  -0.89 (-1.74%)    04-19 16:00
Open: 50.82
High: 51.56
Volume: 540,194
Pre. Close: 51.08
Low: 48.5
Market Cap: 2,558(M)
Technical analysis
2024-04-19 5:11:43 PM
Short term     
Mid term     
Targets 6-month :  63.65 1-year :  74.35
Resists First :  54.5 Second :  63.65
Pivot price 49.72
Supports First :  48.97 Second :  45.56
MAs MA(5) :  51.13 MA(20) :  49.26
MA(100) :  46.07 MA(250) :  38.02
MACD MACD :  0.8 Signal :  0.6
%K %D K(14,3) :  61 D(3) :  64.9
RSI RSI(14): 52.1
52-week High :  54.5 Low :  24.82
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PRCT ] has closed below upper band by 45.2%. Bollinger Bands are 54.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 51.62 - 52.04 52.04 - 52.32
Low: 47.66 - 48.11 48.11 - 48.41
Close: 49.59 - 50.3 50.3 - 50.78
Company Description

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Headline News

Fri, 19 Apr 2024
PROCEPT BioRobotics Announces Board Member Transition - - TipRanks

Thu, 18 Apr 2024
Allspring Global Investments Holdings LLC Sells 761,589 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - MarketBeat

Tue, 16 Apr 2024
Contrasting PROCEPT BioRobotics (NASDAQ:PRCT) and SeaStar Medical (NASDAQ:ICU) - Defense World

Fri, 05 Apr 2024
The Price Is Right For PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Simply Wall St

Thu, 04 Apr 2024
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas - GlobeNewswire

Fri, 01 Mar 2024
US$56.67 - That's What Analysts Think PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Is Worth After These ... - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 51 (M)
Shares Float 44 (M)
Held by Insiders 3.6 (%)
Held by Institutions 91.6 (%)
Shares Short 4,650 (K)
Shares Short P.Month 4,520 (K)
Stock Financials
EPS -2.25
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.53
Profit Margin -77.8 %
Operating Margin -67.9 %
Return on Assets (ttm) -19.2 %
Return on Equity (ttm) -44.4 %
Qtrly Rev. Growth 83.3 %
Gross Profit (p.s.) 0
Sales Per Share 2.67
EBITDA (p.s.) -2.07
Qtrly Earnings Growth 0 %
Operating Cash Flow -108 (M)
Levered Free Cash Flow -106 (M)
Stock Valuations
PE Ratio -22.41
PEG Ratio -2.5
Price to Book value 9.07
Price to Sales 18.78
Price to Cash Flow -23.69
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android